| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 08/12/2009 | CN101503681A Mutant of cyclodextrin glucosyl transferase having highly alpha-cyclodextrin yielding property and mutation method |
| 08/12/2009 | CN101503680A Mutant of cyclodextrin glucosyl transferase having highly beta-cyclodextrin yielding property and mutation method |
| 08/12/2009 | CN101503679A QSOX, mutant protein thereof, as well as preparation and use |
| 08/12/2009 | CN101503678A Malt oligosaccharide based mycose synthetase, coding gene and use |
| 08/12/2009 | CN101503660A Engineering bacteria expressing thermophilic saccharifying enzyme and use thereof |
| 08/12/2009 | CN101503659A Trichoderma harzianum strain and use thereof |
| 08/12/2009 | CN100526473C Method of detecting mild impaired glucose tolerance or insulin hyposecretion |
| 08/12/2009 | CN100526466C Method of controlling ethanol production |
| 08/12/2009 | CN100526459C High-activity phytase composition |
| 08/12/2009 | CN100526458C Alpha-galactosidase gene, its coding protein, production and use |
| 08/12/2009 | CN100526457C 3-phosphoglycerate dehydrogenase variants whose inhibition by L-serine is reduced, and genes encoding them |
| 08/11/2009 | US7572952 Genetic construct with a coding sequence for a gamma -tocopherol methyltransferase operably connected to a plant promoter not natively associated with the coding sequence which when expressed in a plant results in an alteration in the ratio of alpha- gamma tocopherol |
| 08/11/2009 | US7572950 Methods for obtaining pathogen resistance in plants |
| 08/11/2009 | US7572926 Plant desaturases—compositions and uses |
| 08/11/2009 | US7572903 Method of regulation of bacterial persister status |
| 08/11/2009 | US7572899 Compositions and methods for increasing bone mineralization |
| 08/11/2009 | US7572764 Uses of chemically-modified cholinesterases for detoxification of organophosporus compounds |
| 08/11/2009 | US7572634 Compositions and methods for locating preferred integration sites within the genome of a plant |
| 08/11/2009 | US7572628 Eukaryotic layered vector initiation systems |
| 08/11/2009 | US7572619 Using immortalized trangenic cell to express antihemophilic factor and blood coagulation factor IX for treatment of blood disorders |
| 08/11/2009 | US7572618 Atherosclerosis; coronary heart disease; encodes a polypeptide that is capable of lowering the level of LDL uptake in mammalian cells |
| 08/11/2009 | US7572617 Thermostable ribonuclease H obtained from Archeoglobus profundus |
| 08/11/2009 | US7572616 Combating disorders affecting mitochondrial oxidative phosphorylation system by allotopic expression of the cyanide-insensitive alternative oxidase (AOX) in human cells; polynucleotide obtained from Mollusca, Nematoda and Chordata; metabolic, cardiovascular, genetic, and nervous system disorders |
| 08/11/2009 | US7572615 Converts formate to carbon dioxide and hydrogen; derived from Mannheimia succiniciproducens; minimize formate which is produced as a by-product in the production of succinic acid |
| 08/11/2009 | US7572614 Identifying an inhibitor of a glutaminyl cyclase (QC); used to treat QC associated disorders; crystallization |
| 08/11/2009 | US7572613 Drug delivery system for accelerated subcutaneous absorption |
| 08/11/2009 | US7572608 R-hydroxynitrillyases having improved substrate tolerance and the use thereof |
| 08/11/2009 | US7572604 Modified polypeptide; comprising a mutation in at least one of W433, E432 and M439 and the amino acid sequence of an enzyme of glycosyl hydrolase family 1 |
| 08/11/2009 | US7572599 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 08/11/2009 | US7572591 Thrombotic thrombocytopenic purpura (TTP); epitope recognized by an antibody (anti-ADAMTS-13 antibody) against a cleaving protease ( ADAMTS-13) specific to von Willebrand factor |
| 08/11/2009 | US7572438 Mutant having uracil phosphoribosyl transferase activity |
| 08/11/2009 | CA2546660C Selective inhibitors of viral or bacterial neuraminidase |
| 08/11/2009 | CA2348732C Human h37 proteins and cdnas encoding the same |
| 08/11/2009 | CA2342300C Mutant luciferase having increased thermostability |
| 08/11/2009 | CA2328133C Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 08/11/2009 | CA2327254C Chemically modified mutant enzymes and methods for producing them and screening them |
| 08/11/2009 | CA2321263C Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
| 08/11/2009 | CA2224404C Cell volume-regulated human kinase h-sgk |
| 08/06/2009 | WO2009097568A1 Dna repair polypeptides and methods of delivery and use |
| 08/06/2009 | WO2009097346A2 Isolated alcohol dehydrogenase enzymes and uses thereof |
| 08/06/2009 | WO2009097014A2 Therapeutic kinase modulators |
| 08/06/2009 | WO2009096689A2 Improved promoter and a production method for l-lysine using the same |
| 08/06/2009 | WO2009096541A1 Method of producing cysteine derivative |
| 08/06/2009 | WO2009095793A1 New i-crei derived single-chain meganuclease and uses thereof |
| 08/06/2009 | WO2009095742A1 New i-crei derived single-chain meganuclease and uses thereof |
| 08/06/2009 | WO2009095715A1 Cytokinin riboside phosphorylase from potato and its use |
| 08/06/2009 | WO2009095500A1 Inhibitors of lentiviral replication |
| 08/06/2009 | WO2009095366A1 Method for producing sclareol |
| 08/06/2009 | WO2009095278A2 The use of alternan as ingredient for certain foodstuffs |
| 08/06/2009 | WO2009079220A3 Recombinant elastase proteins and methods of manufacturing and use thereof |
| 08/06/2009 | WO2009067218A3 Glucoamylase variants with altered properties |
| 08/06/2009 | WO2009064366A3 Methods and compositions for protein labeling using lipoic acid ligases |
| 08/06/2009 | WO2009063503A3 Process for purification of human tissue type plasminogen activator |
| 08/06/2009 | WO2009058957A3 Intranasal administration of active agents to the central nervous system |
| 08/06/2009 | WO2009051717A3 Human factor ix variants with an extended half life |
| 08/06/2009 | WO2009010444A3 Biopolishing on man-made cellulosic fabric |
| 08/06/2009 | WO2008138131A9 Bone targeted alkaline phosphatase, kits and methods of use thereof |
| 08/06/2009 | WO2007115201A8 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 08/06/2009 | WO2004009778A3 Kinases and phosphatases |
| 08/06/2009 | WO2002074782A3 Isolation and purification procedure of vasopeptidase peptide inhibitors |
| 08/06/2009 | US20090199313 Non-mevalonate isoprenoid pathway |
| 08/06/2009 | US20090199306 Fucosyl transferase gene |
| 08/06/2009 | US20090198047 2'-Modified Oligonucleotides |
| 08/06/2009 | US20090198043 Feline il-18 proteins |
| 08/06/2009 | US20090197869 Azepine inhibitors of janus kinases |
| 08/06/2009 | US20090197817 Tetrahdrofuro[3,2-B] pyrrol-3- one as cathepsin k inhibitors |
| 08/06/2009 | US20090197812 Peptides for Inhibiting Transglutaminase |
| 08/06/2009 | US20090197337 Methods for the production of multimeric proteins and related compositions |
| 08/06/2009 | US20090197336 Suppression of polymorphic alleles |
| 08/06/2009 | US20090197323 Identification and characterization of a novel alpha-amylase from maize endosperm |
| 08/06/2009 | US20090197318 Crystallization of enzyme and method for producing same |
| 08/06/2009 | US20090197317 TSG-Like Gene |
| 08/06/2009 | US20090197316 Process for preparing particles of proteinaceous material |
| 08/06/2009 | US20090197315 Fullerene-based amino acids |
| 08/06/2009 | US20090197314 Modified Microorganisms with Inactivated Lactate Dehydrogenase Gene |
| 08/06/2009 | US20090197309 Mutant Acetolactate Synthase and a Method for Producing Branched-Chain L-Amino Acids |
| 08/06/2009 | US20090197308 Enzymatic synthesis of sulfated polysaccharides |
| 08/06/2009 | US20090197301 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/06/2009 | US20090197300 Mutually exclusive domain folding molecular switch and method of synthesis thereof |
| 08/06/2009 | US20090197273 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 08/06/2009 | US20090197269 Translocation and mutant CSF1R Kinase in human leukemia |
| 08/06/2009 | US20090197252 Detection of Mutations |
| 08/06/2009 | US20090197246 Haplotypes and polymorphisms linked to human thiopurine s-methyltransferase deficiencies |
| 08/06/2009 | US20090196864 Insecticides that target protein kinase a (pka) |
| 08/06/2009 | CA2854933A1 Methods and compositions using soluble klotho proteins |
| 08/06/2009 | CA2729124A1 New i-crei derived single-chain meganuclease and uses thereof |
| 08/06/2009 | CA2712900A1 Dna repair polypeptides and methods of delivery and use |
| 08/06/2009 | CA2712722A1 Isolated alcohol dehydrogenase enzymes and uses thereof |
| 08/06/2009 | CA2712410A1 The use of alternan as ingredient for certain foodstuffs |
| 08/05/2009 | EP2085482A1 Nucleotide sequences which code for the metY gene |
| 08/05/2009 | EP2085472A1 D-serine dehydratase and use thereof |
| 08/05/2009 | EP2085471A2 Modified factor VIIA polypeptides |
| 08/05/2009 | EP2085470A1 FVII or FVIIa variants |
| 08/05/2009 | EP2085469A1 Lipase formulation |
| 08/05/2009 | EP2084974A1 The use of alternan-oligosaccharide as a degradation-resistant ingredient for acidic beverages |
| 08/05/2009 | EP2084293A2 Genetically engineered biological indicator |
| 08/05/2009 | EP2084283A1 Mutant dna polymerases and their genes |
| 08/05/2009 | EP2084274A2 Modified coagulation factor ix polypeptides and use thereof for treatment |
| 08/05/2009 | EP2084273A1 Multiple mutation variants of serine protease |
| 08/05/2009 | EP2084272A1 Clonation, expression and use of acid lysophospholipases |